|
1.
|
Longhi A, Errani C, De Paolis M, et al:
Primary bone osteosarcoma in the pediatric age: state of the art.
Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Meyers PA, Schwartz CL, Krailo M, et al:
Osteosarcoma: a randomized, prospective trial of the addition of
ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and
high dose methotrexate. J Clin Oncol. 23:2004–2011. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Jawad MU, Cheung MC, Clarke J, et al:
Osteosarcoma: improvement in survival limited to high-grade
patients only. J Cancer Res Clin Oncol. 137:597–607. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Rosidah, Yam MF, Sadikun A, et al:
Toxicology evaluation of standardized methanol extract of Gynura
procumbens. J Ethnopharmacol. 123:244–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Nawawi A, Nakamura N, Hattori M, et al:
Inhibitory effects of Indonesian medicinal plants on the infection
of herpes simplex virus type 1. Phytother Res. 13:37–41. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Iskander MN, Song Y, Coupar IM and
Jiratchariyakul W: Antiinf lammatory screening of the medicinal
plant Gynura procumbens. Plant Foods Hum Nutr. 57:233–244.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Hoe SZ, Lee CN, Mok SL, et al: Gynura
procumbens Merr. decreases blood pressure in rats by
vasodilatation via inhibition of calcium channels. Clinics (Sao
Paulo). 66:143–150. 2011. View Article : Google Scholar
|
|
8.
|
Kim MJ, Lee HJ, Wiryowidagdo S and Kim HK:
Antihypertensive effects of Gynura procumbens extract in
spontaneously hypertensive rats. J Med Food. 9:587–590. 2006.
|
|
9.
|
Akowuah GA, Amirin S, Mariam A and Aminah
I: Blood sugar lowering activity of Gynura procumbens leaf
extracts. J Trop Med Plants. 2:5–10. 2001.
|
|
10.
|
Akowuah GA, Sadikun A and Mariam A:
Flavonoid identification and hypoglycaemic studies of butanol
fraction from Gynura procumbens. Pharm Biol. 40:405–410.
2002. View Article : Google Scholar
|
|
11.
|
Rosidah, Yam MF, Sadikun A and Asmawi M:
Antioxidant potential of Gynura procumbens. Pharm Biol.
46:616–625. 2008. View Article : Google Scholar
|
|
12.
|
Zhang XF and Tan BK: Effects of an
ethanolic extract of Gynura procumbens on serum glucose,
cholesterol and triglyceride levels in normal and
streptozotocin-induced diabetic rats. Singapore Med J. 41:9–13.
2000.
|
|
13.
|
Kim J, Lee CW, Kim EK, et al: Inhibition
effect of Gynura procumbens extract on UV-B-induced
matrix-metalloproteinase expression in human dermal fibroblasts. J
Ethnopharmacol. 137:427–433. 2011.
|
|
14.
|
Davies B, Miles DW, Happerfield LC, et al:
Activity of type IV collagenases in benign and malignant breast
disease. Br J Cancer. 67:1126–1131. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Davies B, Waxman J, Wasan H, et al: Levels
of matrix metalloproteases in bladder cancer correlate with tumour
grade and invasion. Cancer Res. 53:5365–5369. 1993.PubMed/NCBI
|
|
16.
|
Iwata H, Kobayashi S, Iwase H, et al:
Production of matrix metalloproteinases and tissue inhibitors of
metalloproteinases in human breast carcinomas. Jpn J Cancer Res.
87:602–611. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Tokuraku M, Sato H, Murakami S, et al:
Activation of the precursor of gelatinase A/72 kDa type IV
collagenase/MMP-2 in lung carcinomas correlates with the expression
of membrane-type matrix metalloproteinase (MT-MMP) and with lymph
node metastasis. Int J Cancer. 64:355–359. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Brown PD, Bloxidge RE, Stuart NS, et al:
Association between expression of activated 72-kilodalton
gelatinase and tumour spread in non-small-cell lung carcinoma. J
Natl Cancer Inst. 85:574–578. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Zhang XX, Fu Z, Zhang Z, et al:
Microcystin-LR promotes melanoma cell invasion and enhances matrix
metalloproteinase-2/-9 expression mediated by NF-κB activation.
Environ Sci Technol. 46:11319–11326. 2012.PubMed/NCBI
|
|
20.
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–74. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Tsuruda T, Costello-Boerrigter LC and
Burnett JC Jr: Matrix metalloproteinases: pathways of induction by
bioactive molecules. Heart Fail Rev. 9:53–61. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Andela VB, Gordon AH, Zotalis G, et al:
NF-kappaB: a pivotal transcription factor in prostate cancer
metastasis to bone. Clin Orthop Relat Res. (415 Suppl): S75–S85.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Felx M, Guyot MC, Isler M, et al:
Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving
the transcription factor NF-kappaB in human osteosarcoma. Clin Sci
(Lond). 110:645–654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Werb Z: ECM and cell surface proteolysis:
regulating cellular ecology. Cell. 91:439–442. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Finco TS and Baldwin AS: Mechanistic
aspects of NF-kappa B regulation: the emerging role of
phosporylation and proteolysis. Immunity. 3:263–272. 1995.
View Article : Google Scholar : PubMed/NCBI
|
